BREAKING NEWS: FDA to greenlight Pfizer COVID-19 booster for children aged 12 to 15 on Monday, report says
- The FDA plans to allow for children aged 12 to 15 to receive the Pfizer COVID booster shot on Monday, according to a New York Times report
- The Omicron COVID-19 variant is tearing across the U.S., and is believed to be resistant to the initial vaccine regimens
The U.S. Food and Drug Administration (FDA) plans to allow for children aged 12 to 15 to receive the Pfizer-BioNTech COVID-19 booster in the new year, according to a report by the New York Times.
Currently the Pfizer booster is only available to people as young as 16, though children as young as five are eligible for the initial two-dose regimen.
The Omicron COVID-19 variant accounts for anywhere between 40 percent to 73 percent of new cases in the United States, according to data from the Centers for Disease Control and Prevention (CDC), and has found to be resistant to the initial two-dose vaccine regiments.
Boosters are believed to be able to re-establish vaccine protection against infection from Omicron, though, leading to a larger nationwide push to getting more Americans the additional shots.
This story is being updated